Thalamic atrophy predicts 5-year disability progression in multiple sclerosis
Frontiers in Neurology K. Hänninen, M. Viitala, T. Paavilainen, J. Karhu, J. Rinne, J. Koikkalainen,…
cDSI helps doctors decide which Alzheimer’s patients are appropriate for lumbar puncture
Alzheimer's proteins in the cerebrospinal fluid play an increasingly important role in an accurate diagnosis. In this article, Dr. Hanneke Rhodius-Meester of the Alzheimer Center Amsterdam explains how cDSI can help doctors decide which patients are appropriate for a lumbar puncture.
Combinostics raises €3.9M to support early Alzheimer’s diagnosis
Combinostics is pleased to announce the closure of a €3.9M series A funding round to extend the company's cNeuro platform in the US and Asia.
Combinostics partners with Nihon Medi-Physics to develop and market cNeuro platform in Japan
Combinostics is pleased to announce an exclusive partnership with Nihon Medi-Physics to develop and market the cNeuro platform in Japan.
Three peer-reviewed, scientific publications that describe the use of cNeuro
Three peer-reviewed, scientific journals have published articles that describe the use of the cNeuro platform for dementias and other cognitive disorders.
